SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    T.E. Silva, G. Colombo, L.L. Schiavon, Adiponectin: A multitasking player in the field of liver diseases, Diabetes & Metabolism, 2014, 40, 2, 95

    CrossRef

  2. 2
    Grégory Merlen, Géraldine Gentric, Séverine Celton-Morizur, Marc Foretz, Jacques-Emmanuel Guidotti, Véronique Fauveau, Jocelyne Leclerc, Benoit Viollet, Chantal Desdouets, AMPKα1 controls hepatocyte proliferation independently of energy balance by regulating Cyclin A2 expression, Journal of Hepatology, 2014, 60, 1, 152

    CrossRef

  3. 3
    Jia Xiao, Chi Tat Ho, Emily C. Liong, Amin A. Nanji, Tung Ming Leung, Thomas Yue Huen Lau, Man Lung Fung, George L. Tipoe, Epigallocatechin gallate attenuates fibrosis, oxidative stress, and inflammation in non-alcoholic fatty liver disease rat model through TGF/SMAD, PI3 K/Akt/FoxO1, and NF-kappa B pathways, European Journal of Nutrition, 2014, 53, 1, 187

    CrossRef

  4. 4
    Ganji Purnachandra Nagaraju, Sheik Aliya, Olatunji Boladale Alese, Role of adiponectin in obesity related gastrointestinal carcinogenesis, Cytokine & Growth Factor Reviews, 2014,

    CrossRef

  5. 5
    Sayaka Inokuchi-Shimizu, Eek Joong Park, Yoon Seok Roh, Ling Yang, Bi Zhang, Jingyi Song, Shuang Liang, Michael Pimienta, Koji Taniguchi, Xuefeng Wu, Kinji Asahina, William Lagakos, Mason R. Mackey, Shizuo Akira, Mark H. Ellisman, Dorothy D. Sears, Jerrold M. Olefsky, Michael Karin, David A. Brenner, Ekihiro Seki, TAK1-mediated autophagy and fatty acid oxidation prevent hepatosteatosis and tumorigenesis, Journal of Clinical Investigation, 2014, 124, 8, 3566

    CrossRef

  6. 6
    Valerio Nobili, Gianluca Svegliati-Baroni, Anna Alisi, Luca Miele, Luca Valenti, Pietro Vajro, A 360-degree overview of paediatric NAFLD: Recent insights, Journal of Hepatology, 2013, 58, 6, 1218

    CrossRef

  7. 7
    Mónica B. Jiménez-Castro, Araní Casillas-Ramírez, Mariana Mendes-Braz, Marta Massip-Salcedo, Jordi Gracia-Sancho, María Elias-Miró, Juan Rodés, Carmen Peralta, Adiponectin and resistin protect steatotic livers undergoing transplantation, Journal of Hepatology, 2013, 59, 6, 1208

    CrossRef

  8. 8
    Chiou-Feng Lin, Kung-Chia Young, Chyi-Huey Bai, Bu-Chin Yu, Ching-Ting Ma, Yu-Chieh Chien, Hui-Chen Su, Hue-Yu Wang, Chao-Sheng Liao, Hsin-Wen Lai, Chiung-Wen Tsao, Blockade of reactive oxygen species and Akt activation is critical for anti-inflammation and growth inhibition of metformin in phosphatase and tensin homolog-deficient RAW264.7 cells, Immunopharmacology and Immunotoxicology, 2013, 35, 6, 669

    CrossRef

  9. 9
    Bo Hyun Kim, Jung-Hwan Yoon, Jong In Yang, Sun Jung Myung, Jeong-Hoon Lee, Eun Uk Jung, Su Jong Yu, Yoon Jun Kim, Hyo-Suk Lee, Chung Yong Kim, Guggulsterone attenuates activation and survival of hepatic stellate cell by inhibiting nuclear factor kappa B activation and inducing apoptosis, Journal of Gastroenterology and Hepatology, 2013, 28, 12
  10. 10
    Ching-Fen Wu, Yun-Lian Lin, Yi-Tsau Huang, Hepatitis C virus core protein stimulates fibrogenesis in hepatic stellate cells involving the obese receptor, Journal of Cellular Biochemistry, 2013, 114, 3
  11. 11
    Christopher Savard, Erica V. Tartaglione, Rahul Kuver, W. Geoffrey Haigh, Geoffrey C. Farrell, Savitha Subramanian, Alan Chait, Matthew M. Yeh, LeBris S. Quinn, George N. Ioannou, Synergistic interaction of dietary cholesterol and dietary fat in inducing experimental steatohepatitis, Hepatology, 2013, 57, 1
  12. 12
    Benson T. Akingbemi, G Protein-Coupled Receptors in Energy Homeostasis and Obesity Pathogenesis, 2013,

    CrossRef

  13. 13
    Kenji Kato, Takanobu Otsuka, Akira Kondo, Rie Matsushima-Nishiwaki, Hideo Natsume, Osamu Kozawa, Haruhiko Tokuda, AMP-activated protein kinase regulates PDGF-BB-stimulated interleukin-6 synthesis in osteoblasts: Involvement of mitogen-activated protein kinases, Life Sciences, 2012, 90, 1-2, 71

    CrossRef

  14. 14
    Joong-Yeon Lim, Min-A Oh, Won Ho Kim, Hee-Young Sohn, Sang Ick Park, AMP-activated protein kinase inhibits TGF-β-induced fibrogenic responses of hepatic stellate cells by targeting transcriptional coactivator p300, Journal of Cellular Physiology, 2012, 227, 3
  15. 15
    Le Thi Thanh Thuy, Norifumi Kawada, Antifibrotic role of macrophage migration inhibitory factor: Discovery of an unexpected function, Hepatology, 2012, 55, 4
  16. 16
    Mahmoud Aboelneen Khattab, Mohammed Eslam, Mayada M. Aly, Mohammed Shatat, Azaa Hussen, Yossef I. Moussa, Ghada Elsaghir, Hesham Abdalhalim, Ahmed Aly, Salwa Gaber, Stephen A. Harrison, Association of Serum Adipocytokines With Insulin Resistance and Liver Injury in Patients With Chronic Hepatitis C Genotype 4, Journal of Clinical Gastroenterology, 2012, 46, 10, 871

    CrossRef

  17. 17
    Emmanuelle Berger, Nathalie Vega, Hubert Vidal, Alain Geloën, Gene network analysis leads to functional validation of pathways linked to cancer cell growth and survival, Biotechnology Journal, 2012, 7, 11
  18. 18
    Ashwin Woodhoo, Marta Iruarrizaga-Lejarreta, Naiara Beraza, Juan L García-Rodríguez, Nieves Embade, David Fernández-Ramos, Nuria Martínez-López, Virginia Gutiérrez-De Juan, Beatriz Arteta, Juan Caballeria, Shelly C Lu, José M Mato, Marta Varela-Rey, María L Martínez-Chantar, Human antigen R contributes to hepatic stellate cell activation and liver fibrosis, Hepatology, 2012, 56, 5
  19. 19
    M. Fuerst, C. G. Taylor, B. Wright, L. Tworek, P. Zahradka, Inhibition of smooth muscle cell proliferation by adiponectin requires proteolytic conversion to its globular form, Journal of Endocrinology, 2012, 215, 1, 107

    CrossRef

  20. 20
    Jay V. Patankar, Sascha Obrowsky, Prakash Doddapattar, Gerald Hoefler, Michele Battle, Sanja Levak-Frank, Dagmar Kratky, Intestinal GATA4 deficiency protects from diet-induced hepatic steatosis, Journal of Hepatology, 2012, 57, 5, 1061

    CrossRef

  21. 21
    Feng Zhang, Yin Lu, Shizhong Zheng, Peroxisome proliferator-activated receptor-γ cross-regulation of signaling events implicated in liver fibrogenesis, Cellular Signalling, 2012, 24, 3, 596

    CrossRef

  22. 22
    Feng Fang, Lei Liu, Yang Yang, Zenshiro Tamaki, Jun Wei, Roberta G Marangoni, Swati Bhattacharyya, Ross S Summer, Boping Ye, John Varga, The adipokine adiponectin has potent anti-fibrotic effects mediated via adenosine monophosphate-activated protein kinase: novel target for fibrosis therapy, Arthritis Research & Therapy, 2012, 14, 5, R229

    CrossRef

  23. 23
    Wei Zhang, Rong Wu, Feng Zhang, Yizhi Xu, Bo Liu, Yingying Yang, Huamei Zhou, Lulu Wang, Keqiang Wan, Xiaoqiu Xiao, Xia Zhang, Thiazolidinediones improve hepatic fibrosis in rats with non-alcoholic steatohepatitis by activating the adenosine monophosphate-activated protein kinase signalling pathway, Clinical and Experimental Pharmacology and Physiology, 2012, 39, 12
  24. 24
    Maurizio Parola, Fabio Marra, Adipokines and Redox Signaling: Impact on Fatty Liver Disease, Antioxidants & Redox Signaling, 2011, 15, 2, 461

    CrossRef

  25. 25
    Josef Wanninger, Markus Neumeier, Sabrina Bauer, Thomas S. Weiss, Kristina Eisinger, Roland Walter, Christoph Dorn, Claus Hellerbrand, Andreas Schäffler, Christa Buechler, Adiponectin induces the transforming growth factor decoy receptor BAMBI in human hepatocytes, FEBS Letters, 2011, 585, 9, 1338

    CrossRef

  26. 26
    Mahnoush S. Shafiei, Shoba Shetty, Philipp E. Scherer, Don C. Rockey, Adiponectin Regulation of Stellate Cell Activation via PPARγ-Dependent and -Independent Mechanisms, The American Journal of Pathology, 2011, 178, 6, 2690

    CrossRef

  27. 27
    Mark F. McCarty, Full-spectrum antioxidant therapy featuring astaxanthin coupled with lipoprivic strategies and salsalate for management of non-alcoholic fatty liver disease, Medical Hypotheses, 2011, 77, 4, 550

    CrossRef

  28. 28
    D. Heinrichs, M. Knauel, C. Offermanns, M.-L. Berres, A. Nellen, L. Leng, P. Schmitz, R. Bucala, C. Trautwein, C. Weber, J. Bernhagen, H. E. Wasmuth, Macrophage migration inhibitory factor (MIF) exerts antifibrotic effects in experimental liver fibrosis via CD74, Proceedings of the National Academy of Sciences, 2011, 108, 42, 17444

    CrossRef

  29. 29
    Virginia Hernandez-Gea, Scott L. Friedman, Pathogenesis of Liver Fibrosis, Annual Review of Pathology: Mechanisms of Disease, 2011, 6, 1, 425

    CrossRef

  30. 30
    Stergios A. Polyzos, Konstantinos A. Toulis, Dimitrios G. Goulis, Christos Zavos, Jannis Kountouras, Serum total adiponectin in nonalcoholic fatty liver disease: a systematic review and meta-analysis, Metabolism, 2011, 60, 3, 313

    CrossRef

  31. 31
    Ning-Ping Foo, Shu-Huei Lin, Yu-Hsuan Lee, Ming-Jiuan Wu, Ying-Jan Wang, α-Lipoic acid inhibits liver fibrosis through the attenuation of ROS-triggered signaling in hepatic stellate cells activated by PDGF and TGF-β, Toxicology, 2011, 282, 1-2, 39

    CrossRef

  32. 32
    Vlad Ratziu, Stefano Bellentani, Helena Cortez-Pinto, Chris Day, Giulio Marchesini, A position statement on NAFLD/NASH based on the EASL 2009 special conference, Journal of Hepatology, 2010, 53, 2, 372

    CrossRef

  33. 33
    Jeffrey A. Handy, Neeraj K. Saxena, Pingping Fu, Songbai Lin, Jamie E. Mells, Nitika A. Gupta, Frank A. Anania, Adiponectin activation of AMPK disrupts leptin-mediated hepatic fibrosis via suppressors of cytokine signaling (SOCS-3), Journal of Cellular Biochemistry, 2010, 110, 5
  34. 34
    Song Hwa Choi, Young Woo Kim, Sang Geon Kim, AMPK-mediated GSK3β inhibition by isoliquiritigenin contributes to protecting mitochondria against iron-catalyzed oxidative stress, Biochemical Pharmacology, 2010, 79, 9, 1352

    CrossRef

  35. 35
    Alexander James Thompson, Keyur Patel, Antifibrotic Therapies: Will We Ever Get There?, Current Gastroenterology Reports, 2010, 12, 1, 23

    CrossRef

  36. 36
    Maho Sumiyoshi, Masahiro Sakanaka, Yoshiyuki Kimura, Chronic intake of a high-cholesterol diet resulted in hepatic steatosis, focal nodular hyperplasia and fibrosis in non-obese mice, British Journal of Nutrition, 2010, 103, 03, 378

    CrossRef

  37. 37
    Gisèle Nkontchou, Jean-Philippe Bastard, Marianne Ziol, Mounir Aout, Emmanuel Cosson, Nathalie Ganne-Carrie, Véronique Grando-Lemaire, Dominique Roulot, Jacqueline Capeau, Jean-Claude Trinchet, Eric Vicaut, Michel Beaugrand, Insulin resistance, serum leptin, and adiponectin levels and outcomes of viral hepatitis C cirrhosis, Journal of Hepatology, 2010, 53, 5, 827

    CrossRef

  38. 38
    Gabriela Velasco-Loyden, Julio Isael Pérez-Carreón, José Fernando Cabello Agüero, Pilar Cabrales Romero, Susana Vidrio-Gómez, Lidia Martínez-Pérez, Lucia Yáñez-Maldonado, Rolando Hernández-Muñoz, Marina Macías-Silva, Victoria Chagoya de Sánchez, Prevention of in vitro hepatic stellate cells activation by the adenosine derivative compound IFC305, Biochemical Pharmacology, 2010, 80, 11, 1690

    CrossRef

  39. 39
    Stergios A. Polyzos, Jannis Kountouras, Christos Zavos, Eleni Tsiaousi, The role of adiponectin in the pathogenesis and treatment of non-alcoholic fatty liver disease, Diabetes, Obesity and Metabolism, 2010, 12, 5
  40. 40
    Stephen A. Harrison, Thiazolidinedione therapy for nonalcoholic steatohepatitis: Go, stop, or proceed with caution?, Hepatology, 2010, 51, 2
  41. 41
    Fabio Marra, Cristiana Bertolani, Adipokines in liver diseases, Hepatology, 2009, 50, 3
  42. 42
    B. Viollet, B. Guigas, J. Leclerc, S. Hébrard, L. Lantier, R. Mounier, F. Andreelli, M. Foretz, AMP-activated protein kinase in the regulation of hepatic energy metabolism: from physiology to therapeutic perspectives, Acta Physiologica, 2009, 196, 1
  43. 43
    Alain Da Silva Morais, Jorge Abarca-Quinones, Bruno Guigas, Benoit Viollet, Peter Stärkel, Yves Horsmans, Isabelle A. Leclercq, Development of hepatic fibrosis occurs normally in AMPK-deficient mice, Clinical Science, 2009, 118, 6, 411

    CrossRef

  44. 44
    Masayuki Adachi, Hiromasa Ishii, Hyperadiponectinemia in alcoholic liver disease: Friend or foe?, Journal of Gastroenterology and Hepatology, 2009, 24, 4
  45. 45
    Nicolas Lanthier, Yves Horsmans, Isabelle A Leclercq, The metabolic syndrome: how it may influence hepatic stellate cell activation and hepatic fibrosis, Current Opinion in Clinical Nutrition and Metabolic Care, 2009, 12, 4, 404

    CrossRef

  46. 46
    Yoshihiro Kamada, Tetsuo Takehara, Norio Hayashi, Adipocytokines and liver disease, Journal of Gastroenterology, 2008, 43, 11, 811

    CrossRef

  47. 47
    Montserrat Moreno, Ramon Bataller, Cytokines and Renin-Angiotensin System Signaling in Hepatic Fibrosis, Clinics in Liver Disease, 2008, 12, 4, 825

    CrossRef

  48. 48
    Ye Gao, Yi Zhou, Aimin Xu, Donghai Wu, Effects of an AMP-Activated Protein Kinase Inhibitor, Compound C, on Adipogenic Differentiation of 3T3-L1 Cells, Biological & Pharmaceutical Bulletin, 2008, 31, 9, 1716

    CrossRef

  49. 49
    Basel al-Ramadi, Adrian Hayday, Wilhelm Schwaeble, Immunology in the Arabian desert, Nature Immunology, 2008, 9, 7, 699

    CrossRef

  50. 50
    Kiyotaka Watanabe, Shin Ohnishi, Ichiro Manabe, Ryozo Nagai, Takashi Kadowaki, KLF6 in Nonalcoholic Fatty Liver Disease: Role of Fibrogenesis and Carcinogenesis, Gastroenterology, 2008, 135, 1, 309

    CrossRef

  51. 51
    Samuele De Minicis, Ekihiro Seki, Christoph Oesterreicher, Bernd Schnabl, Robert F. Schwabe, David A. Brenner, Reduced nicotinamide adenine dinucleotide phosphate oxidase mediates fibrotic and inflammatory effects of leptin on hepatic stellate cells, Hepatology, 2008, 48, 6